Tata India Pharma & Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹166 Cr | ₹949 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open-ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.34 | 2.21 |
| Manager | Rohan Korde | Meeta Shetty |
| ISIN Code | INF00XX01BL5 | INF277K016A9 |
| Exits Load | Exit load of 1% if redeemed within 12 months./365 | Exit load of 0.25% if redeemed within 30 days./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | 6.02% | 7.23% |
| 6 Month | 20.76% | 21.76% |
| 1 Year | 49.89% | 52.93% |
| 3 Year | - | 19.75% |
| 5 Year | - | 28.8% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 14.47% | 17.22% |
| 3 Year | 35.63% | 42.6% |
| 5 Year | 35.63% | 77.31% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 18.13% | 24.61% |
| 3 Year | 38.24% | 52.38% |
| 5 Year | 38.24% | 78.63% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 14.52% | 14.23% |
| Sharp | - | 0.74% |
| Beta | - | 0.9% |
| Alpha | - | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Rohan Korde | Meeta Shetty |
| Total AUM | ₹4626 Cr | ₹17847 Cr |
| Fund Manage | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 0.48 | 5.34 |
| Mid Cap | 28.05 | 39.68 |
| Small Cap | 32.19 | 16.33 |
| Large Cap | 39.28 | 38.65 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 0.48 | 3.05 |
| Healthcare | 96.77 | 93.35 |
| Chemicals | 2.75 | 1.31 |
| Services | - | 2.29 |
Top Comparisons
UTI - Gilt Fund - Regular Plan - Growth Option
3Y Returns5.64%
Edelweiss Government Securities Fund - Regular Plan - Growth Option
3Y Returns6.08%
Mahindra Manulife Focused Fund - Regular Plan - Growth
3Y Returns24.43%
Quant Focused Fund-Growth
3Y Returns22.43%
ITI Banking and Financial Services Fund Regular - Growth
3Y Returns0%
Nippon India Banking and Financial Services Fund-Growth Plan-Growth Option
3Y Returns18.87%
HDFC Banking and Financial Services Fund - Growth Option
3Y Returns15.12%
Sundaram Financial Services Opportunities Fund Regular Plan - Growth
3Y Returns19.35%